Related by context. All words. (Click for frequent words.) 82 RESTASIS 76 Elestat 73 ELESTAT ® epinastine HCl 71 Benicar R 69 Benicar ® 68 AZASITE 67 ACEON R 65 AndroGel R 65 ACEON ® 65 * olmesartan medoxomil 65 azithromycin ophthalmic solution 65 Femring ® 64 epinastine HCl ophthalmic 63 R epinastine HCl 63 AzaSite ® 63 Benicar HCT 62 Restasis R 62 Sensipar R 61 OLUX 61 Azactam 61 Orthovisc ® 61 AZOR TM 61 Angelini Labopharm 60 AVINZA 60 unconsolidated joint 60 Retail Leathercraft 60 VANTAS 60 STRIANT 60 PRAVACHOL R 60 Recurring royalties 60 bacterial conjunctivitis Elestat 60 LIDODERM 60 SANCTURA XR 59 RITUXAN 59 Azmacort R 59 COLAZAL R 59 Testim R 59 INTEGRILIN R eptifibatide Injection 59 GLUMETZA 59 PMPS brand 59 Lidoderm ® 58 Lipofen R 58 Dorzolamide 58 TACLONEX 58 ARCALYST R 58 OPANA franchise 58 LUCENTIS r 58 GLUMETZA ® 58 3Q FY# representing 58 Evoclin R 58 BD Biosciences segment 58 Ribavirin royalties 58 Programmer Paradise segment 58 LUMIGAN R 57 Noninterest Expense Noninterest expense 57 Besivance 57 Frova R 57 RMB#.#million 57 Kyowa Kirin 57 Nascobal R 57 agreements AndroGel 57 Sanctura 57 ABILIFY R 57 BUPHENYL R 57 Rexahn licensees 57 Scantron segment decreased 57 Noninterest expense totaled 57 Xibrom TM 57 Noven Therapeutics 57 BioGlue R 57 Esprit Pharma 57 totaled USD#.#m 57 BEPREVE 57 risedronate sodium tablets 57 Currency translation negatively impacted 57 Polymer Additives segment 57 RLEC adjusted EBITDA 57 Cardiac Surgery Systems 57 ZYFLO CR 57 Zanaflex 57 noninterest expense totaled 56 DOVONEX 56 Dovonex 56 KADIAN R 56 Soriatane R 56 Lidoderm R 56 Positively impacting 56 Benicar 56 Aloxi injection 56 bimatoprost ophthalmic solution 56 BioGlue ® 56 BioSante licensees 56 Monovisc TM 56 LIFO inventory decrement 56 DepoDur R 56 HealthStream Learning 56 4Q FY# 56 Argatroban 56 Rapaflo 56 Istalol 56 Empatic ™ 56 Enablex 56 Luxiq 56 SinuNase ™ 56 BioMarin Genzyme LLC 56 Orthovisc R 56 Aldara ® 56 Kerastick ® 56 Wireline adjusted EBITDA 56 Timolol ophthalmic solution 56 antibiotic Zyvox 56 Vancocin R 56 ZANAFLEX CAPSULES 56 ALTACE 56 ACTONEL 55 Tridural 55 RAPTIVA r 55 Trelstar R 55 noninterest expense decreased 55 ethinyl estradiol tablets USP 55 MARRIOTT REVENUES totaled 55 SUPPRELIN LA 55 Niobe ® 55 Normalized EPS 55 CARBATROL 55 TPIAO 55 phytosterol revenues 55 CRINONE R 55 Hesperion acquisition 55 ECR Pharmaceuticals 55 Custom folding carton 55 BUPHENYL R sodium phenylbutyrate 55 AndroGel ® 55 Zegerid OTC 55 3Q FY# 55 Nasdaq PGNX today 55 ZALBIN ™ 55 generic oral contraceptives 55 5 lipoxygenase inhibitor 55 Yidasheng totaled RMB#.# 55 INTEGRILIN 55 Wellbutrin XL R 55 rilonacept Injection 55 copromotion 55 Clinical Diagnostics segment 55 methylnaltrexone bromide 55 Favourable Changes total 55 Wholesale Leathercraft 55 AVINZA ® 55 cinacalcet HCl 55 Broadspire segment 55 nine monthsended 55 ZALBIN 55 XYREM 55 Hugoton Properties 55 Besivance TM 55 Partnered Brands segment 55 Somatuline ® 55 Noninterest expense decreased 55 INTEGRILIN ® 55 Actimmune R 55 VANTAS R 55 ZYFLO R 55 Naprelan 55 OshKosh wholesale 54 Megace R ES 54 OLEPTRO ™ 54 prioryear 54 gallium arsenide GaAs substrate 54 palonosetron hydrochloride injection 54 Nuo Hua 54 Trelstar ® 54 CLARINEX 54 Benicar HCT R 54 EKR Therapeutics 54 Frova ® 54 Licorice Products segment 54 Lexiscan R 54 netsales 54 BioGlue revenues 54 sumatriptan succinate 54 SORL consolidated 54 millioncompared 54 ascompared 54 Womacks Adjusted EBITDA 54 Combunox 54 Biaxin clarithromycin 54 Chlor Alkali segment 54 Maxipime 54 PENTASA 54 Nabi HB 54 BLU U R 54 Voltaren Gel 54 erlotinib Tarceva R 54 Polyphenon ® E 54 1Q FY# representing 54 Nascobal ® 54 mequinol 54 evaluated Swad 54 FROVA 54 ARCALYST ® 54 Eligard ® 54 EBITDAO 54 Ethyol 54 Benazepril 54 RAPTIVA R 54 Milestone Payments 54 clobetasol propionate Foam 54 Pennsaid ® 54 Downstream CCS 54 Treximet ® 54 Lung Rx 54 Orapred ODT 54 FACTIVE R gemifloxacin 54 XAGRID 54 Ditropan XL 54 Postpay ARPU 54 XLGB 54 XOPENEX 54 IV Infusion Therapy 54 Prepaid churn 54 Crofelemer budesonide foam 54 Humibid 54 Retransmission consent revenue 54 ABELCET 53 ZEGERID ® 53 OPANA ER 53 Cedax 53 OPANA 53 Agenerase 53 Prepaid ARPU 53 morphine sulfate extended 53 fexofenadine hydrochloride 53 Ixempra 53 Vitaflo Scandinavia AB 53 ZEGERID Capsules 53 Bilive 53 Deposition Paris Hilton 53 Taclonex Scalp R 53 DORYX 53 Pravachol cholesterol lowering 53 ZYFLO ® 53 thrombopoietin TPO 53 SUPPRELIN R LA 53 Procardia XL 53 BLU U ® 53 Comparable coffeehouse 53 Baobaole chewable tablets 53 Goodbye Santika 53 DELATESTRYL 53 PULMICORT 53 Pexeva 53 Drivetrain segment 53 Kineret R 53 VISICOL R 53 Gross Profit Gross 53 Mircette R 53 Sinobiopharma 53 ACEON R perindopril erbumine 53 mg sodium bicarbonate 53 Gross Margin Gross 53 SOLODYN R 53 earnings pershare 53 INFeD R 53 Exterran stockholders 53 ACTIQ 53 Fanapt iloperidone 53 Xeloda ® 53 Components Segment 53 Sustiva efavirenz 53 #.#per diluted 53 STRIANT ® 53 Scantron segment increased 53 MVAS gross 53 CCXA 53 #F YTD 53 PDP MLR 53 Azithromycin Dispersible Tablets 53 Lilly ICOS joint venture 53 YTD Fiscal 53 GTSP 53 Silenor ® doxepin 53 Wellbutrin SR 53 Oxandrin 53 Ultane Sevorane 53 tacrolimus capsules 53 Tridural TM 53 ZEGERID R 53 granulated mesalamine 53 dutogliptin 53 Surgical Adhesive 53 nonsedating antihistamine 53 RAZADYNE 53 totaled EUR#.#m 53 SunOpta Foods 53 Purse TBA 53 Explosive Metalworking segment 53 R sorafenib tablets 53 Vicente Padilla rhp 53 NEUPOGEN R 53 Zipsor 53 Proquin XR 53 Fine Chemicals segment 53 R Interferon beta 53 ONTAK 53 OIBDAN declined 52 Mg Uk 52 PERCOCET 52 TEB adjustment 52 Craftmade segment 52 ASUR regulated 52 Valacyclovir 52 Amnesteem 52 Oxy ER 52 Unigene nasal calcitonin 52 Fortigel 52 Silenor ® 52 ImmunoCyt TM uCyt + 52 R rilonacept Injection 52 Bextra Geodon Zyvox 52 AmericanSingles segment 52 Kerastick 52 Ultracet R 52 Kerastick R 52 Lilly ICOS 52 RepHresh ® 52 Lilly ICOS LLC 52 USD #.#bln [001] 52 Subcutaneous Use 52 Naprelan R 52 Neulasta R 52 CRIC shareholders 52 operating income1 52 Sumatriptan Succinate 52 eptifibatide Injection 52 Estrostep 52 Sirton 52 nalbuphine ER 52 Actonel R 52 Captisol ® 52 Auxilium Pharma 52 TOFUTTI brand 52 IV APAP 52 SUSTIVA R 52 nonoperating expense 52 FHLB borrowings decreased 52 MERREM IV 52 Duramed Pharmaceuticals 52 ridaforolimus 52 Cardene R 52 Shire BioChem Inc. 52 Wholesale Leathercraft posted 52 IV Busulfex 52 ZYFLO 52 CAMH combines 52 levocetirizine 52 Duromist 52 promissory note receivable 52 collaborator Bayer HealthCare 52 Radix Isatidis dispersible tablets 52 Zorbtive TM 52 Peyronie disease Frozen Shoulder 52 StromaCel Inc. 52 Cetirizine Hydrochloride Syrup 52 R hylan GF 52 torsemide ER 52 Klean Prep TM 52 ended September# 52 Prandin 52 AGY Asia 52 Testim 52 date Wholesale Leathercraft 52 ferumoxytol Injection 52 KADIAN ® 52 Thalomid ® 52 Astelin 52 stock basedcompensation 52 AllOne Mobile Corporation 52 therapeutically inactive prodrug 52 Oxytrol R 52 Nascobal 52 ZANAFLEX tablets 52 Vivelle Dot ® 52 Gelnique 52 ABILIFY ® 52 Novogyne 52 1Q FY# 52 adjusted OIBDA decreased 52 JPY8 52 Kosan dependence 52 Exalgo 52 Amaryl R 52 Oracea 52 Femring 52 Sanofi Aventis Allegra 52 topical gel formulation 52 Non CWI 52 Non GAAP Operating Margin 52 dacetuzumab collaboration 52 USD#.#m [008] 52 Rx Pharmaceuticals 52 Nycomed GmbH 52 Motorhome Resorts Segment 52 Overall NewMarket 52 hypertension drugs Cozaar 52 Akorn Strides 51 Refissa 51 ZEGERID omeprazole sodium bicarbonate 51 AMMONUL R sodium phenylacetate 51 XOPENEX Inhalation Solution 51 Zyflo CR 51 INEGY 51 ranolazine extended release 51 polymer platinate 51 nasal calcitonin product 51 Astepro 51 Vinyls segment 51 MOVIPREP R 51 Janssen AI 51 STRIANT R 51 Oncaspar 51 Keflex 51 Wellbutrin XL ® 51 Travatan 51 Tecstar Automotive Group 51 #.#bn rub [004] 51 Boniva ibandronate 51 Individual Annuities segment 51 RYZOLT 51 #.#/diluted share 51 per dilutedshare 51 2Q FY# representing 51 PLAVIX R 51 R fluocinolone acetonide 51 bakery cafe sales 51 Segment adjusted OIBDA 51 WhiteWave Morningstar 51 tramadol ER 51 fracture proppant 51 Additive Technologies 51 Vacation Interval sales 51 USD#.#m [007] 51 Fenoglide 51 markets Testim ® 51 Retail Leathercraft posted 51 THROMBIN JMI ® 51 InvaGen 51 Unitrin Direct segment 51 include ClindaReach TM 51 CHF #.#M 51 Fortical R 51 OLEPTRO TM 51 RESTYLANE R 51 Forlax R 51 Paperboard Packaging segment 51 Almay color 51 RAPTIVA 51 Xolegel 51 AMPAC ISP Holdings 51 hepatitis B immune globulin 51 USD #.#mln 51 Angiomax Angiox 51 Soriatane 51 Pro forma EPS 51 Finacea 51 AVONEX ® 51 EBITD 51 Omeprazole 51 DuoNeb 51 TIMERx 51 Dermacyte 51 SOLODYN 51 ZEFFIX 51 Motorized RV Segment 51 mesylate tablets 51 #.# perdiluted 51 THALOMID 51 Pfizer Norvasc 51 Midlothian Laboratories 51 Wyeth Progenics 51 HCl Tablets 51 Curosurf 51 BD Diagnostics segment 51 Fanapt ® 51 AZASAN R 51 Cenestin 51 transdermal fentanyl 51 prescription dermatological 51 TKM ApoB 51 balsalazide disodium Capsules 51 PROTONIX 51 Cold Remedy segment 51 Interest Expense Interest expense 51 Seamap equipment 51 BioAstin 51 NutropinAq ® 51 Levoleucovorin 51 Generics Segment 51 SmartGrowth Deposits 51 Megace R 51 Androgel 51 Release Tablets 51 Nonaccrual loans totaled 51 Cubist Pharmaceuticals NASDAQ CBST 51 comparedto 51 Increlex TM 51 sublingual tablets 51 Besylate 51 Amrix 51 eprodisate KIACTA TM 51 Depakene 51 Cetrotide R 51 Zuplenz 51 Advicor R 51 LIFO provision 51 sumatriptan succinate injection 51 proforma revenues 51 Including discontinued operations 51 Xcytrin R 51 Silenor doxepin 51 Kenwood Therapeutics 51 Olefins segment 51 COLAZAL 51 FARESTON ® 51 interferon alpha Severe 51 Medicis Pharma 51 LOE decreased 51 DIFICID ™ 51 Motorized RV 51 sumatriptan injection 51 Megace ES 51 Intevac Photonics revenues 51 CREON 51 Non GAAP adjusted EBITDA 51 Surfactant gross 51 candidate REP# 51 Solazed 51 Infergen R 50 Partially offset 50 SYCREST 50 pentadentate logo R 50 profit beia 50 Luveris R Ovidrel R 50 BioTie 50 quarterended 50 markets HP Acthar 50 Excluding goodwill impairment 50 ZEGERID OTC 50 RMB4 #.# 50 Loan originations totaled 50 TOLMAR Holding Inc. 50 HP Acthar r 50 Nonperforming loans decreased 50 THALOMID R 50 LIFO inventory valuation 50 Eligard R 50 plus aztreonam 50 REVENUES Revenues 50 Glumetza 50 Diluted HEPS 50 Taiho Pharmaceutical 50 SEASONALE R 50 NMP# R 50 Womacks casino 50 Bristol Myers Squibb Pravachol 50 markets COLAZAL 50 Phosphates segment 50 docetaxel prednisone alone 50 LIALDA MEZAVANT 50 R memantine HCl 50 Zovirax ® 50 Pliaglis 50 Alphagan P 50 tazarotene 50 ESTRASORB ® 50 zileuton tablets 50 Evoclin 50 Meritage Pharma 50 Arixtra ® 50 Q1 #F 50 Zirgan 50 Aloxi R 50 CRINONE 50 Twinject ® 50 Cetirizine 50 increaseof 50 Viagra Soft Cialis Soft 50 AMK Welding 50 RYZOLT TM 50 Methylin 50 excluding WStore 50 tamsulosin hydrochloride 50 loss NOL carryforward 50 AstraZeneca Toprol XL 50 Endoscopic Technologies 50 BMGP advertising 50 Ps.3 50 HIV integrase inhibitor 50 Filgrastim 50 IVUS disposable 50 SpeBio joint venture 50 RMB2 #.# 50 REVENUE Revenue 50 Didronel 50 olmesartan medoxomil hydrochlorothiazide 50 USD#.#m USD#.# per [002] 50 Aloxi ® 50 #mg dosages 50 #.Net 50 kroner euro#.# [002] 50 metformin hydrochloride 50 ketoconazole USP Gel 50 research anddevelopment 50 GlaxoSmithKline Zofran 50 infliximab monotherapy 50 R bisoprolol Euthyrox 50 Engineered Material Systems 50 Preclinical eValuation 50 barrels MMBbls 50 VSL # 50 PTH1 50 Mucinex R 50 Merck Sante sas 50 GVAX ® 50 dextromethorphan quinidine 50 Hycamtin ® 50 Suppository Hydrocortisone Acetate Rectal 50 Milestone Payment 50 Preotact ® 50 Enjuvia 50 Fiber Optics segment 50 Somatuline R Depot 50 mucopolysaccharidosis VI MPS VI 50 Oilseeds Processing operating 50 R pegaptanib sodium 50 Mometasone 50 Targretin capsules 50 Emezine 50 PRAVACHOL 50 MOVIPREP 50 Tiuxetan 50 proprietary chemically modified 50 Submitted Pursuant 50 operatingincome 50 Axid 50 MOXATAG 50 syndrome overactive bladder 50 Sumatriptan 50 Xin Aoxing 50 LUVOX CR 50 Announces Tentative Approval 50 balsalazide 50 ONCASPAR 50 CPRK advertising 50 segment Accredo Health 50 fludarabine phosphate 50 Qutenza ® 50 Reyataz atazanavir 50 Taclonex 50 Somatuline Depot 50 subtracting commissions paid 50 MVAS revenues 50 generic Flomax 50 ® bortezomib 50 Unfavourable Changes 50 Allegra ® 50 Colazal 50 excluding BIBP 50 anincrease 50 Loratadine 50 PictureMe Portrait Studio 50 PhosLo R 50 ESTRASORB 50 MFB Corp 50 elotuzumab 50 per MCFE 50 Teveten 50 Zevalin R Ibritumomab 50 NYSE Amex AIS 50 Pfizer Camptosar 50 apaziquone 50 Hectorol R 49 Akorn Strides LLC 49 Currency translation effects 49 Xatral R 49 fiscal# 49 Gabitril 49 Xenazine ® 49 losartan potassium 49 Naglazyme R 49 interferon gamma 1b 49 Lasertel subsidiary 49 intangible impairment 49 cyclobenzaprine hydrochloride extended 49 Fentanyl Taifun 49 Launches Generic Version 49 blockbuster cholesterol reducer 49 Replens ® 49 RMB#.# billion [001] 49 Consolidated EBITDA Margin 49 Decapeptyl R 49 Tianyin achieved 49 Oravig 49 mg3 web 49 ASTELIN 49 ARCALYST ® rilonacept 49 counter brand ESOTERICA 49 Churn Rate 49 Suprax R 49 Androgel R 49 Altoprev 49 NutropinAq R 49 PTOI 49 Fluticasone Propionate 49 continuingoperations 49 ZETIA totaled 49 Flector Patch 49 ofapproximately 49 please visit http:/www.vandapharma.com 49 fexofenadine HCl 49 Newsstand Distribution Services 49 PANZYTRAT 49 Wyeth Pristiq 49 Galderma SA 49 Sanctura XR 49 5 HT3 antagonist 49 KK Supply Chain 49 Celgene Thalomid 49 Humulin 49 Focalin XR ® 49 - Non Shane Germann 49 Zanaflex tablets 49 Cutivate 49 oxycodone hydrochloride extended 49 Benda Ebei 49 Evista raloxifene 49 JPY6 49 #mg dosage strength 49 Angio Seal TM 49 FINANCIAL DETAILS 49 5mg #mg 49 cents ashare 49 ` #cr [002] 49 Dexilant 49 Lamictal ODT 49 Ganciclovir 49 Annualized ROE 49 FUEL CHEM segment 49 Mucinex ® 49 Doryx 49 Surgical Implant Division 49 SEK #.#M #.# 49 IncreaseRx 49 Teveten HCT 49 AMRIX 49 Q1 FY'# 49 iii Ps 49 AmBisome 49 OREO write downs 49 Isomedix Services 49 kiwifruit puree 49 approximately RMB8 49 BTG plc 49 Reimbursable costs 49 Ethypharm SA 49 GlaxoSmithKline Imitrex 49 GRALISE 49 Preprint revenues 49 DSD Dairy segment 49 collectibles snack foods 49 Pruvel TM 49 Lexiscan ® 49 Pulmicort Respules 49 hydrochloride tablets 49 #.#mg #mg 49 JUVISTA 49 AlloDerm R 49 FiberChoice 49 Darinaparsin Zinapar TM 49 Ranexa R 49 Submits NDA 49 HCD# [002] 49 Mestinon 49 Aganocide TM 49 INSPIRE Trial Phase III 49 evaluating satraplatin 49 Peginterferon alfa 2b 49 Nasacort 49 Housewares Segment 49 topical ocular 49 Normalized EBITDA 49 Clindesse R 49 ® chorionic gonadotropin 49 NanoKnife IRE System 49 Therapeutic Antibodies segment 49 sameperiod 49 APRISO 49 HYVISC R 49 UNDERWRITING LIMITATION b 49 Cardene 49 NET REVENUES 49 metoprolol succinate 49 platelet aggregation inhibitor 49 Naglazyme galsulfase 49 c Includes 49 incentive accruals 49 Receives Approvable Letter 49 Amlodipine Besylate Tablets 49 Specialty Engineered Alloys 49 EUR#.#million 49 Aprovel R 49 R Woodfield Suites 49 Bertek Pharmaceuticals 49 highly purified pasteurized 49 -By Cliodhna McGowan 49 MetroGel R 49 trospium chloride 49 Clindesse TM 49 DiaMed acquisition 49 R exenatide injection 49 Trelstar 49 Nabumetone 49 generic Adderall XR 49 Inhalation Aerosol 49 Klean Prep ® 49 ESTRASORB R 49 Repliform R revenues 49 Elestrin 48 Aircraft Modifications 48 theprior 48 chicken Snack Wraps 48 NitroMist 48 Kerastick ® revenues 48 Thalomid R 48 FDA APPROVES 48 Oracea R 48 Prenate Elite 48 Roche OTC RHHBY 48 BIOGUARD TM 48 Processed Minerals 48 Unitrin Specialty segment 48 LUMIGAN 48 ENTOCORT EC 48 CAELYX 48 Regentek 48 Operating Expenses Operating 48 ® ranolazine extended 48 VALSTAR 48 totaled EUR#.# 48 Inc. NASDAQ HITK 48 enoxaparin sodium injection 48 NYSE AMEX LCI 48 Immunotherapeutic 48 NETg acquisition 48 Atelvia 48 EUR -#.# -#.# [001] 48 Evamist TM 48 Ultane 48 deducting underwriters 48 Humulin ® 48 Nicomide R 48 thefourth quarter 48 Amnesteem Claravis 48 FEMCON FE 48 Feraheme ® 48 Twinject R 48 specialty injectables 48 reagent disc 48 Opana ® 48 Explosive Metalworking 48 Solaraze 48 Visa MasterCard antitrust 48 9M FY# [002] 48 BPE Segment 48 MNOK #.# 48 RMB3 #.# 48 Mg Usa 48 disposable handpieces 48 #mg Tablets [002] 48 Olux E 48 octreotide acetate 48 MMdM 48 Lipofen 48 Evaporative Cooling segment 48 EPIAO 48 Efudex 48 TRISENOX ® 48 Sentigen Biosciences 48 ORG domains 48 Harland Acquisition 48 Amerifit 48 FOOTWEAR Down 48 Pro forma adjusted EBITDA 48 duloxetine hydrochloride 48 CAPHOSOL R 48 generic oral contraceptive 48 mg Tablets 48 SEASONIQUE R 48 Ondansetron 48 Towable RV 48 months endedSeptember 48 clipping coupons slashing 48 CalFirst Bancorp 48 MEP Joint Venture 48 Generic Accutane 48 quarter offiscal 48 Fazenda Brasileiro Mine 48 RMB#.# [001] 48 ProEthic 48 mg/# mg tablets 48 Non GAAP Gross Margin 48 Q# revs 48 Printed Products 48 ev3 peripheral vascular 48 Fresenius Kabi achieved 48 Precose 48 Fx adj 48 Tiazac 48 Sensipar ® 48 #.#B +#.# 48 Crinone 48 Suprax 48 totaled MEUR 48 AAM SG 48 Oxandrin R 48 Bupropion HCl ER 48 generic oxaliplatin 48 quarter# 48 MA PFFS 48 Avicena presently derives 48 RMB#.# [006] 48 developing adecatumumab 48 Brovana 48 EBITA amounted 48 MoviPrep 48 ninemonths ended 48 OraTest R 48 adjusted2 48 Adjusted EBITDA1 48 Tritace R 48 D Stat Flowable 48 ninemonths 48 Gynazole 1 48 Aerostructures segment 48 Research Program LFRP 48 NASDAQ PGNX 48 Refractories segment 48 Medicare Advantage premiums 48 MiraLAX 48 EpiPen Auto Injector 48 Roadway Sensors 48 hydrocodone polistirex 48 OSMOPREP TM 48 ALN VSP Phase 48 Glucophage XR 48 Lodrane 48 GROSS LOSS 48 LIFO adjustment 48 Separation Filtration Systems 48 Group Motorise International 48 OP Unit 48 About.com ConsumerSearch.com UCompareHealthCare.coShahrulneeza 48 OSMOPREP 48 Ortho Cept 48 Bayer Yasmin 48 thequarter 48 oxybutynin chloride 48 www.equityallianceir.com 48 CRIXIVAN 48 Adoxa 48 Jeffrey Davidoff Maytag 48 Astaris joint venture 48 Kasco segment 48 divalproex ER 48 memantine HCl 48 Favourable Changes 48 EBITDA1 48 Nippon Shinyaku 48 Celladon Corporation 48 ULTRASE 48 cycle oral contraceptive 48 contractual minimums 48 TRELSTAR ® 48 Nonperforming loans totaled 48 oxycodone HCl controlled 48 CRINONE ® 8 48 intersegment revenues 48 monthsended 48 CNOA shareholders 48 AnGes MG Inc. 48 trazodone hydrochloride 48 Acular 48 Vasotec 48 Halotron revenues 48 Asentar TM 48 novel orally inhaled 48 TRACON Pharmaceuticals 48 Million Milestone Payment 48 Covidien Mallinckrodt